GSDME was shown to be sensitive to a number of anti-neoplastic drugs among others, which is reported to be suppressed via epigenetic inactivation in various cancers and considered as a tumor suppressor gene (34, 35, 61, 62). This evidence concerns the gene GSDME and neoplasm.